![Willem de Vos](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Willem de Vos
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
MicroDish BV
![]() MicroDish BV Miscellaneous Commercial ServicesCommercial Services MicroDish BV manufactures miniature culture chip technology platforms. It provides microdish culture chip, a disposable for the culture of microorganisms and offers custom culture chips. The company was founded by Willem M. de Vos, Colin Ingham and Martin Hessing in 2008 and is headquartered in Utrecht, the Netherlands.
3
| Private Company | Miscellaneous Commercial Services | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Willem de Vos via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Icos Capital Management BV
![]() Icos Capital Management BV Investment ManagersFinance Icos Capital Management BV (ICM) is an independent private equity investment firm headquartered in Badhoevedorp, Netherlands. ICM is the investment manager of Icos Cleantech Fund I (also known as Dutch Technology Fund I) and Icos Cleantech Growth Fund II. Their first fund was co-founded by ICM, CSM, Imtech, Farm Frites, and also gets support from the Dutch Ministry of Economic Affairs. | Investment Managers | Chief Investment Officer | |
Radboud University Nijmegen | College/University | Doctorate Degree | |
Photanol BV
![]() Photanol BV BiotechnologyHealth Technology Photanol BV produces biotechnology based commercial organic chemicals. It offers biofuels and organic compounds by using and combining the properties of photosynthetic and fermenting bacteria, solar energy and carbon dioxide. The company was founded by Klaas Hellingwerf and Joost Texeira de Mattos in 2008 and is headquartered in Amsterdam, the Netherlands. | Biotechnology | Director/Board Member | |
BiOrion Technologies BV
![]() BiOrion Technologies BV Pharmaceuticals: GenericHealth Technology BiOrion Technologies BV develops therapeutic drugs for the cancer and inflammatory diseases. It operates as a pre-clinical stage biopharmaceutical company that developing targeted therapies and companion imaging diagnostics for personalized treatment of patients with fibrosis. The firm develops advanced personalized medicine drugs for simultaneous diagnosis and treatment of diseases such as liver- and pancreatic cancer, liver cirrhosis and kidney fibrosis through specific targeting to PDGF- and IGF-II-expressing diseased cells. The company was founded by Martin Hessing, Klaas Poelstra and Herman Steen in 2003 and is headquartered in Groningen, the Netherlands. | Pharmaceuticals: Generic | Founder | |
Podiceps BV | Founder | ||
SERM Therapeutics BV | Founder | ||
AM-Pharma BV
![]() AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Founder | |
SERPINx BV
![]() SERPINx BV Pharmaceuticals: MajorHealth Technology SERPINx BV develops and distributes protein therapeutics. The firm provides novel serine protease inhibitor (serpin) therapeutics for inflammatory-associated diseases. The company is headquartered in Utrecht, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
Nederland | 11 |
Verenigd Koninkrijk | 2 |
Sectoraal
Health Technology | 6 |
Commercial Services | 3 |
Finance | 2 |
Consumer Services | 2 |
Operationeel
Founder | 7 |
Chief Executive Officer | 4 |
Director/Board Member | 3 |
Chief Operating Officer | 3 |
Chief Investment Officer | 1 |
Sterkste connecties
Insiders | |
---|---|
Martin Hessing | 8 |
Peter van Gelderen | 5 |
Colin Ingham | 1 |
- Beurs
- Insiders
- Willem de Vos
- Bedrijfsconnecties